Functional Genomics of G Protein-Coupled Receptors
Functional Genomics of G Protein-Coupled Receptors
批准号:
10010909
负责人:
Sriram Kosuri
金额:
$24.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2020-10-31
关键词:
AffectAgonistAmino AcidsAmplifiersBar CodesBindingBiological AssayBlindnessCalciumCalcium SignalingCalcium-Sensing ReceptorsCell LineCell physiologyCellsChemicalsComplexCyclic AMPCyclic AMP ReceptorsDNA biosynthesisDNA sequencingDiseaseDrug TargetingEngineeringEnvironmentEpitopesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGeneticGenetic TranscriptionGenetic VariationGenome engineeringHealthHormonesHumanHuman Cell LineIndividualInformaticsLibrariesMammalian CellMeasuresMediator of activation proteinMelanocortin 4 ReceptorMembraneMethodologyMethodsMissense MutationMolecularMutationMutation AnalysisNatural Product DrugNonsense MutationObesityOdorsOligonucleotidesOutputPathway interactionsPharmaceutical PreparationsPharmacogenomicsPhasePhysiologicalPhysiologyPlayPopulationProteinsProxyReceptor SignalingReporterRoleRunningSignal PathwaySignal TransductionStimulusSystemTechnologyTherapeutic InterventionUnited States Food and Drug AdministrationVariantalpha-Melanocyte stimulating hormonebaseburden of illnessdesignfunctional genomicsgain of functiongene functiongenetic variantgenome editingimprovedinnovationinsightloss of functionmutantnext generationnext generation sequencingnovelnovel therapeuticsprotective effectreceptorreceptor expressionreceptor functionresponsetargeted treatmenttechnology development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
G protein-coupled receptors (GPCRs) are central mediators of mammalian cells’ ability to sense and respond
to their environment. The 813 human GPCRs are the largest class of membrane receptors, are central
mediators of cell physiology, and are the target of ~34% of all U.S. Food and Drug Administration
(FDA)-approved drugs and ~60% of prescriptions. Here we will leverage recent advances in DNA synthesis,
genome editing, next-generation DNA sequencing, and informatics develop a platform to build thousands of
individual mutations to GPCRs and experimentally characterize their effects in a novel assay that can be done
in a simple pooled format in human cell lines. We will develop methodologies to characterize how these
mutational libraries functionally signal through the two major pathways that GPCRs signal through, the cyclic
AMP and calcium signaling pathways. The profiles will give us the ability to better understand the functional
consequences of genetic variation in GPCRs and how they might be impacting diseases and drug responses.
In addition, analysis of these mutational profiles will give us insights on how to target these receptors for
making new drugs. The technologies developed here should be broadly and directly applicable to the vast
majority of GPCRs, as well as other important classes of drug targets where function can be assessed by
transcriptional reporters in human cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REVERSE GENOMICS OF REGULATORY ELEMENTS GOVERNING SPLICING
-
批准号:8752770
-
项目类别:
-
资助金额:$231.0万
-
财政年份:2014
-
负责人:Sriram Kosuri
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: